Abdominal Cancer Recruiting Phase 1 / 2 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0036156 (Abdominal Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03762785Pharmacokinetics and Dynamics of Nebulized DexmedetomidinePrevention